183 related articles for article (PubMed ID: 35956064)
41. Bing-Neel syndrome: a case report and systematic review of clinical manifestations, diagnosis, and treatment options.
Grewal JS; Brar PK; Sahijdak WM; Tworek JA; Chottiner EG
Clin Lymphoma Myeloma; 2009 Dec; 9(6):462-6. PubMed ID: 19951888
[TBL] [Abstract][Full Text] [Related]
42. Bing-Neel syndrome with a paravertebral mass.
Suzuki D; Sato D; Kikuchi K; Suzuki T; Sugasawa K; Saito S; Uchimura F; Suzuki Y
Am J Med Sci; 2023 Oct; 366(4):316-320. PubMed ID: 37473959
[TBL] [Abstract][Full Text] [Related]
43. Orbital involvement in Bing-Neel syndrome.
Stacy RC; Jakobiec FA; Hochberg FH; Hochberg EP; Cestari DM
J Neuroophthalmol; 2010 Sep; 30(3):255-9. PubMed ID: 20548243
[TBL] [Abstract][Full Text] [Related]
44. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
45. Successful Treatment of Bing-Neel Syndrome Accompanying Waldenström's Macroglobulinemia with R-MPV: A Case Report.
Kikukawa Y; Yamamura-Fujimoto A; Endo S; Miyagawa E; Kawano Y; Ueno S; Mitsuya H; Hata H; Okuno Y
J Clin Exp Hematop; 2015; 55(2):113-9. PubMed ID: 26490525
[TBL] [Abstract][Full Text] [Related]
46. Bing-Neel syndrome: Two unexpected cases and a review of the literature.
Van Cauwenberge MG; Depreter B; Dumoulin EN; Emmerechts J; Nollet F; Vanopdenbosch LJ
J Neurol Sci; 2015 Sep; 356(1-2):19-26. PubMed ID: 26159625
[TBL] [Abstract][Full Text] [Related]
47. Bing-Neel syndrome - Bilateral cavernous sinus lymphoma causing visual failure.
Pham C; Griffiths JD; Kam A; Hunn MK
J Clin Neurosci; 2017 Nov; 45():134-135. PubMed ID: 28765059
[TBL] [Abstract][Full Text] [Related]
48. Bing Neel Syndrome: A Rare Contributing Factor of Psychosis and Suicidality.
Alexander AL; Jackson D; Donahue JE; Chirkov A; Banerjee P
Am J Forensic Med Pathol; 2023 Jun; 44(2):136-139. PubMed ID: 36989081
[TBL] [Abstract][Full Text] [Related]
49. Bing-Neel syndrome: an illustrative case and a comprehensive review of the published literature.
Malkani RG; Tallman M; Gottardi-Littell N; Karpus W; Marszalek L; Variakojis D; Kaden B; Walker M; Levy RM; Raizer JJ
J Neurooncol; 2010 Feb; 96(3):301-12. PubMed ID: 19618118
[TBL] [Abstract][Full Text] [Related]
50. Novel diagnostic approaches in Bing-Neel syndrome.
Ly KI; Fintelmann F; Forghani R; Schaefer PW; Hochberg EP; Hochberg FH
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):180-3. PubMed ID: 21856555
[TBL] [Abstract][Full Text] [Related]
51. Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non-Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study.
Brandefors L; Sander B; Lundqvist K; Kimby E
Br J Haematol; 2022 Mar; 196(6):1362-1368. PubMed ID: 34959252
[TBL] [Abstract][Full Text] [Related]
52. [Bing-Neel syndrome: Report of 4 cases and literature review].
Boudin L; Romeo E; Mavrovi E; Tsitsi Nding P; Blade JS; de Jaureguiberry JP; Gisserot O
Rev Med Interne; 2015 Jun; 36(6):418-22. PubMed ID: 24907109
[TBL] [Abstract][Full Text] [Related]
53. Bilateral Choroidal Infiltrates as the Initial Manifestation of Waldenström Macroglobulinemia Relapse.
Tan J; Chandra V; Hall AJ
J Vitreoretin Dis; 2022; 6(2):158-162. PubMed ID: 37008658
[TBL] [Abstract][Full Text] [Related]
54. Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).
Cencini E; Romano I; Ghio F; Camerini C; Bertaggia I; Giachetti R; Mannelli L; Pirrotta MT; Navei GL; Ciceri M; Cervetti G; Sant'Antonio E; Simonetti F; Birtolo S; Puccini B; Bocchia M; Fabbri A
Ann Hematol; 2023 Apr; 102(4):841-849. PubMed ID: 36735074
[TBL] [Abstract][Full Text] [Related]
55. Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
Leblond V; Johnson S; Chevret S; Copplestone A; Rule S; Tournilhac O; Seymour JF; Patmore RD; Wright D; Morel P; Dilhuydy MS; Willoughby S; Dartigeas C; Malphettes M; Royer B; Ewings M; Pratt G; Lejeune J; Nguyen-Khac F; Choquet S; Owen RG
J Clin Oncol; 2013 Jan; 31(3):301-7. PubMed ID: 23233721
[TBL] [Abstract][Full Text] [Related]
56. Managing complications secondary to Waldenström's macroglobulinemia.
Pessach I; Dimopoulos MA; Kastritis E
Expert Rev Hematol; 2021 Jul; 14(7):621-632. PubMed ID: 34170207
[No Abstract] [Full Text] [Related]
57. Bing-Neel Syndrome revisited.
Fintelmann F; Forghani R; Schaefer PW; Hochberg EP; Hochberg FH
Clin Lymphoma Myeloma; 2009 Mar; 9(1):104-6. PubMed ID: 19362988
[TBL] [Abstract][Full Text] [Related]
58. Bing-Neel syndrome presenting with bilateral lumbar radiculopathy: A case report of a rare clinical entity.
Brotis AG; Palassopoulou M; Kapsalaki EZ; Paschalis T; Papastergiou V; Fountas KN
Neurocirugia (Astur : Engl Ed); 2022; 33(5):250-253. PubMed ID: 36084961
[TBL] [Abstract][Full Text] [Related]
59. Bing-Neel syndrome revealing Waldenström's macroglobulinemia: a case report.
Jennane S; El Maaroufi H; Mahtat EM; Mikdame M; Doghmi K
Tunis Med; 2020 Oct; 98(10):750-753. PubMed ID: 33479948
[TBL] [Abstract][Full Text] [Related]
60. Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.
Morita K; Yoshimi A; Masuda A; Ichikawa M; Yatomi Y; Kurokawa M
Int J Hematol; 2013 Aug; 98(2):247-9. PubMed ID: 23743950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
